Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8815 |
High Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8815 |
High Similarity |
NPD3620 |
Phase 2 |
0.8582 |
High Similarity |
NPD6674 |
Discontinued |
0.8321 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8014 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7971 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7945 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7826 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7826 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7792 |
Intermediate Similarity |
NPD37 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7754 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD3092 |
Approved |
0.773 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.771 |
Intermediate Similarity |
NPD228 |
Approved |
0.7682 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7654 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7552 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7531 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7531 |
Intermediate Similarity |
NPD27 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7464 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7453 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7388 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7376 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7309 |
Approved |
0.731 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7266 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7206 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7194 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD7095 |
Approved |
0.719 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7143 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7132 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1283 |
Approved |
0.708 |
Intermediate Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1091 |
Approved |
0.698 |
Remote Similarity |
NPD6663 |
Approved |
0.6975 |
Remote Similarity |
NPD2801 |
Approved |
0.6975 |
Remote Similarity |
NPD5929 |
Approved |
0.6975 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD5588 |
Approved |
0.6972 |
Remote Similarity |
NPD3019 |
Approved |
0.6972 |
Remote Similarity |
NPD4059 |
Approved |
0.6962 |
Remote Similarity |
NPD6090 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7159 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD2232 |
Approved |
0.6944 |
Remote Similarity |
NPD2233 |
Approved |
0.6944 |
Remote Similarity |
NPD2230 |
Approved |
0.6944 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD6124 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD2490 |
Approved |
0.6932 |
Remote Similarity |
NPD2488 |
Approved |
0.6928 |
Remote Similarity |
NPD2438 |
Suspended |
0.6928 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6913 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6912 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6908 |
Remote Similarity |
NPD6896 |
Approved |
0.6908 |
Remote Similarity |
NPD6895 |
Approved |
0.6908 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6905 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6899 |
Remote Similarity |
NPD2532 |
Approved |
0.6899 |
Remote Similarity |
NPD2534 |
Approved |
0.6899 |
Remote Similarity |
NPD1809 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD3645 |
Discontinued |
0.6899 |
Remote Similarity |
NPD2533 |
Approved |
0.6894 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.689 |
Remote Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD290 |
Approved |
0.6887 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7054 |
Approved |
0.6879 |
Remote Similarity |
NPD8313 |
Approved |
0.6879 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD8312 |
Approved |
0.6875 |
Remote Similarity |
NPD1281 |
Approved |
0.6875 |
Remote Similarity |
NPD1611 |
Approved |
0.6871 |
Remote Similarity |
NPD2977 |
Approved |
0.6871 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD2978 |
Approved |
0.6867 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6867
|
Remote Similarity |
NPD8032 |
Phase 2 |